Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and transferrin

sorafenib has been researched along with transferrin in 3 studies

Compound Research Comparison

Studies
(sorafenib)		Trials
(sorafenib)		Recent Studies (post-2010)
(sorafenib)		Studies
(transferrin)		Trials
(transferrin)		Recent Studies (post-2010) (transferrin)
6,5207305,25117,5965543,141

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Hanumanthu, PL; Keechilat, P; Koyakutty, M; Malarvizhi, GL; Menon, D; Menon, K; Mony, U; Nair, S; Prabhu, R; Retnakumari, AP; Sidharthan, N; Thampi, MV1
Koyakutty, M; Malarvizhi, GL; Nair, S; Retnakumari, AP1
Chen, D; Fu, J; Hu, H; Li, W; Xin, X1

Other Studies

3 other study(ies) available for sorafenib and transferrin

ArticleYear
Rationally designed aberrant kinase-targeted endogenous protein nanomedicine against oncogene mutated/amplified refractory chronic myeloid leukemia.
    Molecular pharmaceutics, 2012, Nov-05, Volume: 9, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Drug Design; Drug Resistance, Neoplasm; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myeloid Cell Leukemia Sequence 1 Protein; Nanomedicine; Nanoparticles; Niacinamide; Phenylurea Compounds; Phosphorylation; Piperazines; Protein Conformation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Real-Time Polymerase Chain Reaction; Receptors, Transferrin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serum Albumin; Sorafenib; STAT5 Transcription Factor; Transferrin; Tumor Cells, Cultured

2012
Transferrin targeted core-shell nanomedicine for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinoma.
    Nanomedicine : nanotechnology, biology, and medicine, 2014, Volume: 10, Issue:8

    Topics: Apoptosis; Carcinoma, Hepatocellular; Doxorubicin; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Liver Neoplasms; Nanomedicine; Niacinamide; Phenylurea Compounds; Sorafenib; Transferrin

2014
Transferrin-Modified Nanoliposome Codelivery Strategies for Enhancing the Cancer Therapy.
    Journal of pharmaceutical sciences, 2020, Volume: 109, Issue:8

    Topics: Animals; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Humans; Liposomes; Mice; Mice, Inbred BALB C; Neoplasms; Sorafenib; Transferrin

2020